Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 2004

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Contraceptive efficacy and safety of DMPA-SC.

AUTHORS

Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM

SOURCE

Contraception. 2004;70:269-275.

ABSTRACT

DMPA-SC 104 mg/0.65 mL is a new, low-dose subcutaneous (SC) formulation of Depo-Provera contraceptive

injection (150 mg/mL medroxyprogesterone acetate injectable suspension) that provides efficacy, safety and

immediacy of onset equivalent to Depo-Provera intramuscular (IM) injection. Two large, open-label, Phase 3 studies

assessed the 1-year contraceptive efficacy, safety and patient satisfaction with DMPA-SC administered every 3

months (12-13 weeks). Zero pregnancies were reported in both studies, which included a total of 16,023 woman-

cycles of exposure to DMPA-SC and substantial numbers of overweight or obese women. DMPA-SC was well-

tolerated and adverse events were similar to those reported previously with Depo-Provera IM. Thus, DMPA-SC offers

women a new, highly effective and convenient long-acting contraceptive option. (PubHealth.info Document ID:

CONT1T 508-06)

PubHealth.info NOTE: The author(s) of this article titled, "Contraceptive efficacy and safety of DMPA-SC.", is(are)

Jain J; Jakimiuk AJ; Bode FR; Ross D; Kaunitz AM. The source of this article is "Contraception. 2004;70:269-

275.". This article was published in 2004 in English language(s). (PubHealth.info® Document ID: CONT1T 508-06.

All rights reserved with PubHealth.info) PIN: 508

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.